NCT00563108View on ClinicalTrials.gov

Basiliximab for the Treatment of Acute Graft-versus-host Disease After Allogeneic Stem Cell Transplantation

NAUnknownINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

June 30, 2004

Study Completion Date

December 31, 2008

Conditions

Graft vs Host DiseaseHematopoietic Stem Cell Transplantation

Interventions

DRUG

Basiliximab

DRUG

Placebo

Trial Locations (1)

Unknown

RECRUITING

The University of Hong Kong, Hong Kong

Sponsors

Collaborators (1)

Novartis Pharmaceuticals

All Listed Sponsors

collaborator

Novartis Pharmaceuticals

INDUSTRY

collaborator

The Hong Kong Blood Cancer Foundation

OTHER

lead

Hospital Authority, Hong Kong

OTHER_GOV